Analyst firms · Wells Fargo · GKOS
Wells Fargo GKOS price target and rating history
Glaukos Corporation (GKOS) · Health Care
Wells Fargo rates Glaukos Corporation (GKOS) Overweight with a $120 price target, as of its latest action on Oct 27, 2025. It has published 5 rating actions on GKOS since July 2021, including 3 upgrades and 2 downgrades.
- Current rating
- Overweight
- Price target
- $120
- Median target, all firms
- Too few
- Actions on GKOS
- 5
Wells Fargo price target on GKOS
Every Wells Fargo rating on GKOS
- Oct 27, 2025
- May 1, 2025
- Nov 8, 2023
- Jan 19, 2022
- Jul 20, 2021
How other firms rate GKOS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Neutral | Jul 28, 2026 | |
| H.C. Wainwright | Buy | $168 | Jul 6, 2026 |
Questions about Wells Fargo and GKOS
- What is Wells Fargo's price target for GKOS?
- Wells Fargo's latest stated price target for Glaukos Corporation (GKOS) is $120, from its action on Oct 27, 2025.
- What is Wells Fargo's rating on GKOS?
- Wells Fargo rates GKOS Overweight, a bullish rating, as of Oct 27, 2025.
- When did Wells Fargo last change its view on GKOS?
- On Oct 27, 2025, Wells Fargo upgrades to Overweight from Equal Weight, price target $120.
More GKOS rating histories
All Wells Fargo ratingsGKOS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.